Previous studies have demonstrated that loss of GPR56 in CRC cells leads to decreased migration, invasion, and resistance to chemotherapy (12, 13, 16); all of which may potentially be regulated through the Src–Fak pathway. The gene discussed is PTK2; the disease is colorectal carcinoma.